TXMD vs. CORT
Compare and contrast key facts about TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TXMD or CORT.
Key characteristics
| TXMD | CORT | |
|---|---|---|
| YTD Return | -20.45% | 19.67% |
| 1Y Return | -50.56% | 16.13% |
| 3Y Return (Ann) | -63.45% | 23.61% |
| 5Y Return (Ann) | -59.88% | 23.63% |
| 10Y Return (Ann) | -39.57% | 30.65% |
| Sharpe Ratio | -0.79 | 0.27 |
| Daily Std Dev | 62.13% | 55.36% |
| Max Drawdown | -99.98% | -94.28% |
| Current Drawdown | -99.98% | 0.00% |
Fundamentals
| TXMD | CORT | |
|---|---|---|
| Market Cap | $20.64M | $3.98B |
| EPS | -$0.43 | $1.13 |
| PEG Ratio | -0.73 | 0.61 |
| Total Revenue (TTM) | $996.00K | $569.61M |
| Gross Profit (TTM) | -$84.00K | $561.03M |
| EBITDA (TTM) | -$4.27M | $129.11M |
Correlation
The correlation between TXMD and CORT is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TXMD vs. CORT - Performance Comparison
In the year-to-date period, TXMD achieves a -20.45% return, which is significantly lower than CORT's 19.67% return. Over the past 10 years, TXMD has underperformed CORT with an annualized return of -39.57%, while CORT has yielded a comparatively higher 30.65% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TXMD vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TXMD vs. CORT - Dividend Comparison
Neither TXMD nor CORT has paid dividends to shareholders.
Drawdowns
TXMD vs. CORT - Drawdown Comparison
The maximum TXMD drawdown since its inception was -99.98%, which is greater than CORT's maximum drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for TXMD and CORT. For additional features, visit the drawdowns tool.
Volatility
TXMD vs. CORT - Volatility Comparison
TherapeuticsMD, Inc. (TXMD) has a higher volatility of 12.22% compared to Corcept Therapeutics Incorporated (CORT) at 8.97%. This indicates that TXMD's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TXMD vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between TherapeuticsMD, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities